Literature DB >> 1327079

Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer.

R A Stahel1, H Lacroix, J P Sculier, R Morant, J Richner, E Janzek, H Loibner, H Blythman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1327079     DOI： 10.1093/oxfordjournals.annonc.a058193

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Virchows Arch       Date:  2010-03-19       Impact factor: 4.064

2.  Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter.

Authors:  S Kurane; J C Krauss; E Watari; R Kannagi; A E Chang; S Kudoh
Journal:  Jpn J Cancer Res       Date:  1998-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.